Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of locus coeruleus neurons: influence of single and repeated neuroleptic treatment.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001711:Biotransformation / Q000187:drug effects; D002490:Central Nervous System / Q000378:metabolism*; D003024:Clozapine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D006018:Glycols / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D008125:Locus Coeruleus / Q000378:metabolism*; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats
D014150:Antipsychotic Agents; D006018:Glycols; D008734:Methoxyhydroxyphenylglycol; D000242:Cyclic AMP; D003024:Clozapine; D006220:Haloperidol; D009638:Norepinephrine